XILIO THERAPEUTICS INC (XLO): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in XLO · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
5
13F filers
Aggregate Value
$7.7M
Across holders
Last Price
$9.19
2026-08-24
Sector
Health Care
GICS
Quarterly fund activity5 increased0 reduced0 exited
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC CIK 0001055951 | Hedge Fund | 592K | $5.7M | 73.3% | 0.1% | Added | — | Q2 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. CIK 0001165408 | Hedge Fund | 112K | $1.1M | 13.8% | 0.0% | Added | — | Q2 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 64K | $615K | 7.9% | 0.0% | Added | +$140K | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 26K | $249K | 3.2% | 0.0% | Added | — | Q2 2026 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 15K | $139K | 1.8% | 0.0% | Added | — | Q2 2026 |
Added
Hedge Fund
$5.7M· 73.3% of total· 0.1% port· 592K sh· — QoQ· Q2 2026
Added
Hedge Fund
$1.1M· 13.8% of total· 0.0% port· 112K sh· — QoQ· Q2 2026
Added
Hedge Fund
$615K· 7.9% of total· 0.0% port· 64K sh· +$140K QoQ· Q2 2026
Added
Hedge Fund
$249K· 3.2% of total· 0.0% port· 26K sh· — QoQ· Q2 2026
Added
Hedge Fund
$139K· 1.8% of total· 0.0% port· 15K sh· — QoQ· Q2 2026
Loading recent insider activity…